Immunophotonics
is a Pennsylvania-based clinical-stage biotech company that researches and develops novel therapies for the treatment of cancer and infectious diseases... Read moreImmunophotonics
is a Pennsylvania-based clinical-stage biotech company that researches and develops novel therapies for the treatment of cancer and infectious diseases... Read more
News
Oct 28, 2024
GlobalNewswire
Press Release: Immunophotonics : Immunophotonics to Present at the 2024 ThinkEquity Conference
Sep 16, 2024
The Business Journals: St. Louis
Immunophotonics: St. Louis-based cancer drug company launches clinical trial with European partner
Sep 13, 2024
EIN Presswire
Press Release: Immunophotonics : Immunophotonics, CIRSE, and Next Research Announce Innovative Phase 2/3 Clinical Trial: INJECTABL-3
Aug 15, 2024
EIN Presswire
Press Release: Immunophotonics : Immunophotonics Announces 1st Patient Dosed in a Randomized Phase 2 Study at the University of Louisville
Feb 27, 2024
EIN Presswire
Press Release: Immunophotonics : AngioDynamics and Immunophotonics Announces Partnership to Explore the Power of Immunotherapy
Dec 21, 2023
EIN Presswire
Press Release: Immunophotonics : Immunophotonics Announces Research Collaboration to Study Combination of Its Lead Asset with Radiotherapy
Oct 10, 2023
EIN Presswire
Press Release: Immunophotonics : Immunophotonics Announces 1st Patient Dosed in the United States under its Investigational New Drug (IND) Application
Sep 21, 2023
EIN Presswire
Press Release: Immunophotonics : Immunophotonics Announces 1st Patient Dosed in Multinational Clinical trial in France
Jul 12, 2023
EIN Presswire
Press Release: Immunophotonics : Immunophotonics Announces 1st Patient Dosed in Multinational Clinical trial in Germany
May 31, 2023
EIN Presswire
Press Release: Immunophotonics : Immunophotonics Announces 1st Patient Dosed in Multinational Clinical trial in the United Kingdom
Immunophotonics Competitors
1
2
3
4
5
6
7
8
9
10